1-2 of 2
Stefania Girlanda, M.D.
Close
Sort by
Journal Articles

WT1 Transcripts Is a Powerful Leukemia Marker to Predict Early Relapse After Allogeneic Haematopoietic Stem Cell Transplantation.

Carlo Messina, MD, Cristina Tresoldi, Maria Teresa Lupo Stanghellini, MD, Alessandro Crotta, MD, Stefania Girlanda, M.D., Milena Coppola, M.D., Simona Piemontese, M.D., Raffaella Greco, M.D., Simona Malato, M.D., Barbara Forno, M.D., Andrea Assanelli, MD, Daniela Clerici, M.D., Sara Mastaglio, M.D., Fabio Giglio, MD, Marta Bruno Ventre, MD, Francesca Lunghi, M.D., Elena Guggiari, M.D., Matteo Giovanni Carrabba, M.D., Magda Marcatti, M.D., Consuelo Corti, M.D., Chiara Bonini, M.D., Katharina Fleischhauer, M.D., Jacopo Peccatori, M.D., Claudio Bordignon, M.D., Fabio Ciceri, MD, Massimo Bernardi, M.D.
Journal: Blood
Blood (2009) 114 (22): 4488.
https://doi.org/10.1182/blood.V114.22.4488.4488
Published: 2009
Journal Articles

Allogeneic Transplantation with a Treosulfan-Fludarabine Conditioning Regimen Is Feasible and Effective in Elderly Patients with Refractory or Relapsed Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS); Preliminary Results From a Single Center Experience.

Massimo Bernardi, MD, Jacopo Peccatori, M.D., Michela Tassara, Alessandro Crotta, Carlo Messina, MD, Maria Teresa Lupo Stanghellini, MD, Barbara Forno, Stefania Girlanda, M.D., Andrea Assanelli, MD, Daniela Clerici, Sara Mastaglio, Annalisa Ruggeri, MD, Simona Malato, Fabio Giglio, MD, Consuelo Corti, M.D., Elena Guggiari, Matteo Giovanni Carrabba, Chiara Bonini, M.D., Fabio Ciceri, MD
Journal: Blood
Blood (2009) 114 (22): 4318.
https://doi.org/10.1182/blood.V114.22.4318.4318
Published: 2009